University Of Pittsburgh

Removing race from estimated glomerular filtration rate equations could result in more Black patients being excluded from anticancer therapy, thus negatively affecting outcomes, according to study results published in The Lancet Oncology.

Patients with resected stage IIB or stage IIC melanoma who received adjuvant pembrolizumab demonstrated a 35% reduction in risk for disease recurrence or death, according to results of the randomized phase 3 KEYNOTE-716 study.

Despite data showing diversity among providers improves patient care and outcomes, barriers remain to increasing the Black, Hispanic/Latinx and Indigenous cardiologist workforce, according to a recent review paper.

Later timing of epinephrine administration in out-of-hospital cardiac arrest was associated with poorer chances of survival to discharge, regardless of presence of a shockable rhythm, but findings were not significant, researchers reported.

An intervention researchers hoped would improve infection management did not significantly reduce antimicrobial use among nursing home residents with dementia, data showed.

The combination of pembrolizumab and low-dose ipilimumab appeared tolerable and led to significant antitumor activity among patients with advanced melanoma who previously failed prior immunotherapy, according to phase 2 study results.

Approximately 84% of patients with autoimmune diseases develop antibodies from the COVID-19 vaccine, compared with 98.1% of healthy health care workers, according to an interim analysis published in MedRxiv.

Elizabeth Wild, a veteran health care executive, has been appointed president of University of Pittsburgh Medical Center’s Hillman Cancer Center.

A surprise move across the country led Denise Charron-Prochownik, PhD, RN, CPNP, to develop a preconception counseling program for teens with diabetes that would eventually become a model adopted by the American Diabetes Association.

In the last year, the COVID-19 pandemic created panic and uncertainty for everyone, but most notably individuals with cancer and other immunosuppressing diseases, and their providers.